Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders - Raithatha SA; Hagel JM; Matinkhoo K; Yu L; Press D; Cook SG; Sharma G; D D; Jensen G; Lee JB; Cai C; Gallant J; et al. (bioRxiv, 2023)